Why Ocean Biomedical (OCEA) Shares Are Climbing Wednesday

Ocean Biomedical, Inc. OCEA shares are climbing higher on Wednesday after the company announced today that an equity analyst coverage report issued by Fundamental Research Corp. ("FRC") has increased FRC's price target of OCEA stock to $17.63 per share, up from FRC's initial report in March 2023 of $16.40.

The Details:

FRC's report highlighted Ocean Biomedical's anticipated $25 million financing facility last month, the company's recently received patents, recently announced positive results from an independent study and Ocean Biomedical's diversified drug development pipeline.

"We are pleased to see our cumulative efforts and growing strengths recognized by Fundamental Research Corp.'s analyst coverage, especially the diverse potential of our core cancer, fibrosis, and infectious disease programs," commented Dr. Chirinjeev Kathuria, executive chairman of Ocean Biomedical.

"We appreciate Fundamental Research Corp.'s close attention to our financial and research news," said Suren Ajjarapu, an Ocean director, "and we will continue our efforts to meet and exceed both shareholder and stakeholder expectations."

OCEA Price Action: According to Benzinga Pro, Ocean Biomedical shares are trading 26% higher at $6.71 at the time of publication.

Image: Qimono from Pixabay

Market News and Data brought to you by Benzinga APIs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments